Literature DB >> 25878179

Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.

Richard J Leventer1, Thomas Scerri2, Ashley P L Marsh2, Kate Pope2, Greta Gillies2, Wirginia Maixner2, Duncan MacGregor2, A Simon Harvey2, Martin B Delatycki2, David J Amor2, Peter Crino2, Melanie Bahlo2, Paul J Lockhart2.   

Abstract

OBJECTIVE: To define causative somatic mutations in resected brain tissue from an infant with intractable epilepsy secondary to hemispheric cortical dysplasia.
METHODS: Whole-exome sequencing was conducted on genomic DNA derived from both resected brain tissue and peripheral blood leukocytes. Comparison of the brain vs blood sequencing results was performed using bioinformatic methods designed to detect low-frequency genetic variation between tissue pairs.
RESULTS: Histopathology of the resected tissue showed dyslamination and dysmorphic neurons, but no balloon cells, consistent with focal cortical dysplasia type IIa. mTOR activation was observed by immunohistochemistry in the dysplasia. A missense mutation (c.4487T>G; p.W1456G) was detected in the FAT domain of MTOR in DNA from the dysplasia but not in lymphocytes. The mutation is predicted damaging (i.e., leading to mTOR activation) and was observed as a low-level mosaic with 8% of cells being heterozygous for the variant.
CONCLUSIONS: We report the novel finding of an MTOR mutation associated with nonsyndromic cortical dysplasia. Somatic-specific mutations in MTOR and related genes should be considered in a broader spectrum of patients with hemispheric malformations and more restricted forms of cortical dysplasia.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25878179      PMCID: PMC4442098          DOI: 10.1212/WNL.0000000000001594

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.

Authors:  Jeong Ho Lee; My Huynh; Jennifer L Silhavy; Sangwoo Kim; Tracy Dixon-Salazar; Andrew Heiberg; Eric Scott; Vineet Bafna; Kiley J Hill; Adrienne Collazo; Vincent Funari; Carsten Russ; Stacey B Gabriel; Gary W Mathern; Joseph G Gleeson
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

2.  DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

Authors:  Timothy R Peterson; Mathieu Laplante; Carson C Thoreen; Yasemin Sancak; Seong A Kang; W Michael Kuehl; Nathanael S Gray; David M Sabatini
Journal:  Cell       Date:  2009-05-14       Impact factor: 41.582

3.  Is focal cortical dysplasia sporadic? Family evidence for genetic susceptibility.

Authors:  Richard J Leventer; Floor E Jansen; Simone A Mandelstam; Alice Ho; Ismail Mohamed; Harvey B Sarnat; Mitsuhiro Kato; Tatsuya Fukasawa; Hirotomo Saitsu; Naomichi Matsumoto; Masayuki Itoh; Renate M Kalnins; Chung W Chow; A Simon Harvey; Graeme D Jackson; Peter B Crino; Samuel F Berkovic; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2014-02-06       Impact factor: 5.864

4.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

Review 5.  mTOR: A pathogenic signaling pathway in developmental brain malformations.

Authors:  Peter B Crino
Journal:  Trends Mol Med       Date:  2011-09-02       Impact factor: 11.951

6.  Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.

Authors:  Ingrid E Scheffer; Sarah E Heron; Brigid M Regan; Simone Mandelstam; Douglas E Crompton; Bree L Hodgson; Laura Licchetta; Federica Provini; Francesca Bisulli; Lata Vadlamudi; Jozef Gecz; Alan Connelly; Paolo Tinuper; Michael G Ricos; Samuel F Berkovic; Leanne M Dibbens
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

7.  Mutations in critical domains confer the human mTOR gene strong tumorigenicity.

Authors:  Avaniyapuram Kannan Murugan; Ali Alzahrani; Mingzhao Xing
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

8.  Detection of human papillomavirus in human focal cortical dysplasia type IIB.

Authors:  Julie Chen; Victoria Tsai; Whitney E Parker; Eleonora Aronica; Marianna Baybis; Peter B Crino
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

9.  Somatic mutations in cerebral cortical malformations.

Authors:  Saumya S Jamuar; Anh-Thu N Lam; Martin Kircher; Alissa M D'Gama; Jian Wang; Brenda J Barry; Xiaochang Zhang; Robert Sean Hill; Jennifer N Partlow; Aldo Rozzo; Sarah Servattalab; Bhaven K Mehta; Meral Topcu; Dina Amrom; Eva Andermann; Bernard Dan; Elena Parrini; Renzo Guerrini; Ingrid E Scheffer; Samuel F Berkovic; Richard J Leventer; Yiping Shen; Bai Lin Wu; A James Barkovich; Mustafa Sahin; Bernard S Chang; Michael Bamshad; Deborah A Nickerson; Jay Shendure; Annapurna Poduri; Timothy W Yu; Christopher A Walsh
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

10.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.

Authors:  Jean-Baptiste Rivière; Ghayda M Mirzaa; Brian J O'Roak; Margaret Beddaoui; Diana Alcantara; Robert L Conway; Judith St-Onge; Jeremy A Schwartzentruber; Karen W Gripp; Sarah M Nikkel; Thea Worthylake; Christopher T Sullivan; Thomas R Ward; Hailly E Butler; Nancy A Kramer; Beate Albrecht; Christine M Armour; Linlea Armstrong; Oana Caluseriu; Cheryl Cytrynbaum; Beth A Drolet; A Micheil Innes; Julie L Lauzon; Angela E Lin; Grazia M S Mancini; Wendy S Meschino; James D Reggin; Anand K Saggar; Tally Lerman-Sagie; Gökhan Uyanik; Rosanna Weksberg; Birgit Zirn; Chandree L Beaulieu; Jacek Majewski; Dennis E Bulman; Mark O'Driscoll; Jay Shendure; John M Graham; Kym M Boycott; William B Dobyns
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

View more
  20 in total

Review 1.  The role of somatic mutational events in the pathogenesis of epilepsy.

Authors:  Philip H Iffland; Peter B Crino
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

2.  Malformations of Cerebral Cortex Development: Molecules and Mechanisms.

Authors:  Gordana Juric-Sekhar; Robert F Hevner
Journal:  Annu Rev Pathol       Date:  2019-01-24       Impact factor: 23.472

3.  Deep Blue "Seq": Fishing for Epilepsy Genes.

Authors:  Zane Lybrand; Jenny Hsieh
Journal:  Epilepsy Curr       Date:  2016 Mar-Apr       Impact factor: 7.500

4.  Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.

Authors:  Longbo Zhang; Tianxiang Huang; Shannon Teaw; Angélique Bordey
Journal:  Epilepsia       Date:  2019-05-24       Impact factor: 5.864

5.  Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.

Authors:  Jang Keun Kim; Jun Cho; Se Hoon Kim; Hoon-Chul Kang; Dong-Seok Kim; V Narry Kim; Jeong Ho Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

6.  Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.

Authors:  Ghayda M Mirzaa; Catarina D Campbell; Nadia Solovieff; Carleton Goold; Laura A Jansen; Suchithra Menon; Andrew E Timms; Valerio Conti; Jonathan D Biag; Carissa Adams; Evan August Boyle; Sarah Collins; Gisele Ishak; Sandra Poliachik; Katta M Girisha; Kit San Yeung; Brian Hon Yin Chung; Elisa Rahikkala; Sonya A Gunter; Sharon S McDaniel; Colleen Forsyth Macmurdo; Jonathan A Bernstein; Beth Martin; Rebecca Leary; Scott Mahan; Shanming Liu; Molly Weaver; Michael Doerschner; Shalini Jhangiani; Donna M Muzny; Eric Boerwinkle; Richard A Gibbs; James R Lupski; Jay Shendure; Russell P Saneto; Edward J Novotny; Christopher J Wilson; William R Sellers; Michael Morrissey; Robert F Hevner; Jeffrey G Ojemann; Renzo Guerrini; Leon O Murphy; Wendy Winckler; William B Dobyns
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

Review 7.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.

Authors:  Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-18       Impact factor: 3.908

8.  Sending Mixed Signals: The Expanding Role of Molecular Cascade Mutations in Malformations of Cortical Development and Epilepsy.

Authors:  Philip H Iffland; Peter B Crino
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

9.  Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy.

Authors:  Rikke S Møller; Sarah Weckhuysen; Mathilde Chipaux; Elise Marsan; Valerie Taly; E Martina Bebin; Susan M Hiatt; Jeremy W Prokop; Kevin M Bowling; Davide Mei; Valerio Conti; Pierre de la Grange; Sarah Ferrand-Sorbets; Georg Dorfmüller; Virginie Lambrecq; Line H G Larsen; Eric Leguern; Renzo Guerrini; Guido Rubboli; Gregory M Cooper; Stéphanie Baulac
Journal:  Neurol Genet       Date:  2016-10-31

10.  PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution.

Authors:  Ghayda Mirzaa; Andrew E Timms; Valerio Conti; Evan August Boyle; Katta M Girisha; Beth Martin; Martin Kircher; Carissa Olds; Jane Juusola; Sarah Collins; Kaylee Park; Melissa Carter; Ian Glass; Inge Krägeloh-Mann; David Chitayat; Aditi Shah Parikh; Rachael Bradshaw; Erin Torti; Stephen Braddock; Leah Burke; Sondhya Ghedia; Mark Stephan; Fiona Stewart; Chitra Prasad; Melanie Napier; Sulagna Saitta; Rachel Straussberg; Michael Gabbett; Bridget C O'Connor; Catherine E Keegan; Lim Jiin Yin; Angeline Hwei Meeng Lai; Nicole Martin; Margaret McKinnon; Marie-Claude Addor; Luigi Boccuto; Charles E Schwartz; Agustina Lanoel; Robert L Conway; Koenraad Devriendt; Katrina Tatton-Brown; Mary Ella Pierpont; Michael Painter; Lisa Worgan; James Reggin; Raoul Hennekam; Karen Tsuchiya; Colin C Pritchard; Mariana Aracena; Karen W Gripp; Maria Cordisco; Hilde Van Esch; Livia Garavelli; Cynthia Curry; Anne Goriely; Hulya Kayserilli; Jay Shendure; John Graham; Renzo Guerrini; William B Dobyns
Journal:  JCI Insight       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.